ASTERDM · NSE · Hospital
Aster DM Quality Care Ltd
What the numbers mean, from its filings and the exchange. Data as of 13 Oct 2026.
Mid Cap · AMFI list Jan-Jun 2026 · Vendor sector: Healthcare
dear
low confidence
No valuation within 120 days; P/E 113 vs peers 56.6 (12th of 14); P/B 8.8 vs peers 6.8 (8th of 13).
Statements through FY2026Prices adjusted for corporate actionsNot yet reviewed by the adversarial model
What is Aster DM Quality Care's share price today?
Aster DM Quality Care last traded at ₹692.10 on the NSE, as of 13 Oct 2026, 1:00 pm IST, up 1.9% on the day, down 3.0% over a year. Its 52-week range is ₹519 to ₹891. The live price is in the app.
₹692.10
+1.9% today
−3.0% over 1 year · NSE, as of 13 Oct 2026, 1:00 pm IST
60 month-end closes, 31 Oct 2021 to 30 Sep 2026, adjusted for splits and bonuses
52-week range46% of the way up
Low ₹519High ₹891
What is Aster DM Quality Care's market cap?
Aster DM Quality Care's market capitalisation is about ₹59,221 crore: what it would cost to buy every share at today's price. That makes it the 76th largest mid cap company we cover.
₹59,221 Cr
Mid Cap76th largest mid cap company
Share price₹692.10
×
Shares in issue86 crore
=
Market cap₹59,221 Cr
Mid Cap means the companies ranked 101 to 250 by size, under SEBI's rules. Shares in issue are worked out from the market cap and the price. What market cap tells you →
Key facts
From the exchange
- Symbol
- NSE: ASTERDM
- ISIN
- INE914M01019
- Cap bucket
- Mid Cap, 76th largest by market cap
- Industry (NSE)
- Healthcare › Healthcare Services › Hospital
- Listed since
- 2018
- Futures and options
- Not traded
Is Aster DM Quality Care overvalued?
Dear, with low confidence: no valuation within 120 days; P/E 113 vs peers 56.6 (12th of 14); P/B 8.8 vs peers 6.8 (8th of 13).
Valuation
Latest price and trailing 12 months
P/E
113.24
vs peers 56.6 · 12th of 14
Price divided by last year's earnings per share: how many years of today's profit you pay for. Learn more →
P/B
8.84
vs peers 6.8 · 8th of 13
Price divided by book value per share: what you pay for each rupee of net assets on the balance sheet. Learn more →
Market cap
₹59,221 Cr
Total market value of all shares, in ₹ crore. Learn more →
Dividend yield
0.5%
vs peers 0.2% · 1st of 8
Last year's dividends as a share of today's price. Learn more →
PEG (vendor)
Not available
P/E divided by the vendor's earnings growth figure, which it does not disclose; a P/E adjusted for how fast profits grow. Learn more →
PEG on our 3-year EPS growth
Not available
P/E divided by the 3-year EPS growth rate from the stored accounts. Learn more →
Is Aster DM Quality Care a quality business?
Quality score 32.4, 11th of 14 in its peer set; WATCH on 28 of 30 flags judged.
Quality and risk
Data as of 13 Oct 2026
Business quality
Not available
The kind of business, which sets the yardstick it is judged by. Learn more →
Quality score
32.4
vs peers 38.4 · 11th of 14
Returns, margins, leverage and consistency against its peers, out of 100. Learn more →
Risk level
WATCH
28 of 30 flags judged
From flags on debt, earnings quality, dilution and price swings. Learn more →
Profitability
ROE
9.6%
vs peers 8.3% · 7th of 14
Return on equity: profit as a share of shareholders' money. Learn more →
ROCE
10.9%
vs peers 10.3% · 7th of 14
Return on capital employed: operating profit as a share of all the capital in the business, debt and equity. Learn more →
Profit margin
6.4%
vs peers 10.9% · 12th of 14
Profit after everything, as a share of revenue. Learn more →
EPS
₹8.24
Trailing 12 months
Profit for each share over the last 12 months.
Inside the app
Get a sneak peek of Valarth
Has Aster DM Quality Care made money for shareholders?
Mixed: −3.0% over one year and +27.4% a year over five years.
Shareholder returns
5-year return
+27.4% a year
Price only
Yearly average price return over five years, bonuses and splits adjusted. Learn more →
Wealth destroyer
No
Five-year total return — price CAGR on bonus- and split-adjusted closes plus the dividend yield — below the 7% a bank fixed deposit paid. Learn more →
Returns
3Y and 5Y are yearly averages
1W
−0.8%1M
−8.3%3M
−16.6%6M
+2.0%1Y
−3.0%3Y
+28.4%5Y
+27.4%Does Aster DM Quality Care pay a dividend?
Yes. Aster DM Quality Care's dividend yield is 0.45% at the latest price; the last payout was ₹3.00 a share, ex-dividend 2 Apr 2026.
Dividends
Per share, by ex-dividend date
Dividend yield0.45%
The past 12 months' dividends as a share of today's price.
2 Apr 2026 · Interim₹3.00
28 Aug 2025 · Final₹1.00
10 Feb 2025 · Interim₹4.00
22 Aug 2024 · Final₹2.00
23 Apr 2024 · Special₹118.00
Payout ratio🔒 In the app
The share of profit paid out as dividends; a very high share leaves little to reinvest.
Dividend growth, 5 years🔒 In the app
How fast the dividend per share has grown a year.
Years without a miss🔒 In the app
How many years in a row a dividend has been paid.
Is Aster DM Quality Care growing?
Revenue 3 years 12.8% a year; profit 3 years -3.0% a year; revenue 5 years -13.4% a year. History break: FY2026 step year (revenue -49%) in the 3- and 5-year growth figures.
Growth
Statements through FY2026 (Mar-26)
Revenue 3 years
12.8% a year
vs peers 19.5% · 12th of 14
Compound annual growth of revenue over three years. Learn more →
↯
History break: FY2026 step year (revenue -49%) in the 3- and 5-year growth figures.
Profit 3 years
-3.0% a year
vs peers 12.3% · 12th of 14
Compound annual growth of net profit over three years. Learn more →
↯
History break: FY2026 step year (revenue -49%) in the 3- and 5-year growth figures.
Revenue 5 years
-13.4% a year
Compound annual growth of revenue over five years. Learn more →
↯
History break: FY2026 step year (revenue -49%) in the 3- and 5-year growth figures.
Profit 5 years
-9.5% a year
Compound annual growth of net profit over five years. Learn more →
↯
History break: FY2026 step year (revenue -49%) in the 3- and 5-year growth figures.
EPS 3 years
-3.6% a year
Growth in earnings per share, so dilution counts against the company. Learn more →
↯
History break: FY2026 step year (revenue -49%) in the 3- and 5-year growth figures.
EPS 5 years
20.7% a year
Growth in earnings per share over five years, so dilution counts against the company. Learn more →
↯
History break: FY2026 step year (revenue -49%) in the 3- and 5-year growth figures.
P/E vs own history
135.4%
vs peers -2.7% · 10th of 11
Today's P/E against its own 5-year median; negative is cheaper than its history. Learn more →
↯
History break: FY2026 step year (revenue -49%) in the 3- and 5-year growth figures.
How did Aster DM Quality Care do last quarter?
Aster DM Quality Care reported revenue of ₹1,311 Cr, up 12.2% on a year earlier and a net profit of ₹29 Cr, down 92.1% in the Jun 2026 quarter.
Latest quarter
Jun 2026
Revenue, latest quarter₹1,311 Cr
+12.2% on a year earlier
What the company took in over the quarter.
Net profit, latest quarter₹29 Cr
−92.1% on a year earlier
What was left for shareholders after every cost and tax.
How does Aster DM Quality Care compare with its peers?
Compared with 13 Hospital; 12th of 14 on P/E; 11th of 14 on quality score.
Compared with 13 Hospital
13 companies
- Aster DM Quality Care Ltd (this page)
- Apollo Hospitals Enterprise Ltd
- Manipal Health Enterprises Ltd
- Max Healthcare Institute Ltd
- Fortis Healthcare Ltd
- Global Health Ltd
- Narayana Hrudayalaya Ltd
- Krishna Institute of Medical Sciences Ltd
- Dr Agarwals Health Care Ltd
- Rainbow Childrens Medicare Ltd
- Park Medi World Ltd
- Yatharth Hospital & Trauma Care Services Ltd
- Healthcare Global Enterprises Ltd
- Jupiter Life Line Hospitals Ltd
Aster DM Quality Care against its peers
Largest 10 of 13 peers, by market cap
CompanyMarket capP/EP/BROEROCE1YQuality 🔒Rank 🔒
Aster DM Quality Care Ltd₹59,221 Cr113.28.89.6%10.9%−3.0%
Narayana Hrudayalaya Ltd₹34,582 Cr42.812.621.0%18.4%−3.8%
Dr Agarwals Health Care Ltd₹15,065 Cr101.96.51.9%5.0%−8.5%
Rainbow Childrens Medicare Ltd₹12,483 Cr44.57.015.7%17.3%−7.7%
Park Medi World Ltd₹10,995 Cr37.59.57.5%10.0%+72.0%
Peer median—56.66.88.3%10.3%−3.7%
Market cap in rupees crore; P/E and P/B on the latest price; 1Y is the price return over a year. A dash is a figure that does not apply or is not reported.
Who owns Aster DM Quality Care?
Aster DM Quality Care is held by promoters 53.7%, foreign institutions 10.3%, domestic institutions 16.5%.
Shareholding pattern
Latest filing, percent of shares
Promoters53.7%
The founders and controlling group.
Foreign institutions10.3%
Overseas funds investing through the FPI route.
Domestic institutions16.5%
Indian insurers, banks, pension and mutual funds together.
Mutual funds15.9%
Indian mutual fund schemes; part of domestic institutions.
Retail and others1.8%
Individual investors and everyone else.
Promoter shares pledged🔒 In the app
Promoter shares given as collateral for loans; a high share is a risk to watch.
Holding trend🔒 In the app
Whether promoters, foreign funds and mutual funds have been adding or selling over recent quarters.
What do analysts say about Aster DM Quality Care?
12 analysts cover Aster DM Quality Care, and the consensus is buy. A consensus is a count of opinions, not a forecast; read it beside the numbers.
Analyst consensus
12 analysts
ConsensusBuy
The rating most covering analysts give the share.
Average target price🔒 In the app
The mean of the analysts' 12-month price targets.
Upside to target🔒 In the app
How far the target sits above or below today's price.
Share rating it a buy🔒 In the app
The share of covering analysts with a buy rating.
What does Aster DM Quality Care do and what is it sensitive to?
Aster DM Healthcare sells hospital services, clinic care, laboratory tests and pharmacy products to patients across five Indian states. Sensitive to: interest rates on variable-rate borrowings (standalone).
Business-model card
FY2025 · 41 verified
6Revenue
3Channels
5Regulators
3Reg. dependencies
4Sensitivities
5Costs
2Geographies
Aster DM Healthcare sells hospital services, clinic care, laboratory tests and pharmacy products to patients across five Indian states. It earns mainly by billing patients (cash or credit, including insurance-covered patients), with revenue recognised net of discounts and insurance disallowances.
Revenue by segment
year ended March 31, 2025 (consolidated)
Hospitals95.4%
Clinics1.4%
Wholesale Pharmacies*3.0%
Others0.2%
Revenue engine
6 verified
Hospital and medical services (largest line by description; order not stated)
Revenue from in-patient and out-patient treatment, recognised as services are rendered and split by cash and credit customers. Interpretation: the excerpt does not give this line's share of revenue.
Sale of pharmacy
A separate revenue line for pharmacy sales. Interpretation: the 203 pharmacies are run by Alfaone Retail Pharmacies Private Limited under a brand licence from Aster, so the mechanism between that licence and this line is not stated.
Canteen services
A separate revenue line for canteen services, recognised at a point in time when control transfers.
3 more statements
Consultancy services
A separate revenue line for consultancy services, recognised as the service is performed under customer agreements.
Other operating income
Comprises primarily revenue from medical courses conducted at the hospital and income from revenue sharing agreements.
Total revenue from operations FY2025
The excerpt states revenue from operations of INR 41,38,46,00,000 in FY 2024-25 (FY 2023-24: INR 36,98,90,00,000). Interpretation: this equals about INR 4,138 crore.
Customers & channels
3 verified
Patients requiring medical assistance and healthcare services
The excerpt names patients as the customer type. Patients pay directly or through insurance, so the claim is about who the customer is.
Insurance-covered patients
Revenue is recognised net of estimated disallowances for insured patients, so insurer rejections reduce reported revenue.
Cash and credit patient categories
Hospital and medical revenue is disaggregated by category of customers (cash and credit) and by in-patient and out-patient treatment, per the company's disaggregation policy.
Regulators
5 verified
Drugs and Cosmetics Act, 1940
Listed among Acts applicable specifically to the Company. Interpretation: it governs the drugs and pharmacy operations in the business.
Pharmacy Act, 1948
Listed among Acts applicable specifically to the Company. Interpretation: it governs the pharmacy line.
The Indian Medical Council Act, 1956
Listed among Acts applicable specifically to the Company. Interpretation: it governs the medical practice carried out in its hospitals.
2 more statements
Digital Personal Data Protection (DPDP) Act
Governs handling of patient data. The company states that non-compliance could lead to penalties.
National Accreditation Board for Hospitals
The company lists NABH among the standards it has adopted for its operations.
Regulatory dependencies
3 verified
Data protection penalties under DPDP
Non-compliance could lead to penalties and reputational risk. Interpretation: stricter data rules would raise compliance cost and could cut the patient-data services the company relies on.
Insurance coverage rules and claim rejections
Revenue is recognised net of estimated disallowances for insured patients. Interpretation: changes in insurer rejection rates move reported revenue directly.
Compliance with applicable healthcare Acts
The company states that continuous compliance with the law avoids penalties and fines and ensures continuous operations. Interpretation: a change in these Acts would change compliance cost and the risk of losing operating continuity.
Sensitivities
4 verified
Interest rates on variable-rate borrowings (standalone)
A 1% increase in MCLR reduces profit by 3.77 (and equity by 3.77) on variable-rate long-term borrowings of 377.38 at 31 March 2025. A 1% decrease raises profit by 3.77. Rising rates hurt; falling rates help.
Rising variable-rate debt raises rate sensitivity (consolidated)
The Group's variable-rate long-term borrowings were 642.18 at 31 March 2025 (4,130.10 a year earlier). The company states its interest-rate sensitivity increased because of additional variable-rate borrowings taken in the year.
Foreign exchange: AED, OMR and US dollar
The company is mainly exposed to these currencies. Interpretation: changes in these rates move profit and equity through foreign-currency monetary items.
1 more statement
INR/AED sensitivity
For a 1% change in INR/AED, the excerpt shows an impact of (0.02) on profit in FY2025 and 1.71 in FY2024. The sign and size vary by year.
Cost inputs
5 verified
Salaries and allowances (consolidated)
Employee cost driver: 686.70 in FY2025 against 609.89 in FY2024, out of total employee benefits expense of 760.39.
Power, water and fuel (consolidated)
Utility cost: 89.83 in FY2025 against 84.94 in FY2024. Interpretation: the company's electricity use is also shown in energy data.
Housekeeping, security and others (consolidated)
Support-service cost: 132.93 in FY2025 against 134.83 in FY2024.
2 more statements
Input materials sourced directly from MSMEs and small producers
36.22% of input materials by value were sourced directly from MSMEs or small producers in FY2025, up from 27.81% in FY2023-24.
Critical medical equipment, pharmaceuticals and utilities
The company says its operations rely on supply chains for these inputs. It cites dependency on single or limited-source suppliers as a risk.
Geographies
2 verified
Five Indian states
The company's national footprint: Andhra Pradesh, Telangana, Maharashtra, Karnataka and Kerala.
Export share of turnover (3.4%)
The excerpt states an export percentage of turnover. Interpretation: this sits alongside a stated count of 0 international countries, so the basis of the figure is not clear.
Each statement is checked word for word against the FY2025 annual report; the passages are in the app.
What changed recently?
Q1 FY2027 results filed (5 Aug 2026).
Change log
8 entries · newest first
- Results filedQ1 FY2027 results filed.
- Results filedQ4 FY2026 results filed.
- Corporate actionInterim Dividend - Rs 3 Per Share.
- Results filedQ3 FY2026 results filed.
- Results filedQ2 FY2026 results filed.
- Corporate actionDividend - Re 1 Per Share.
- Results filedQ1 FY2026 results filed.
- Results filedQ4 FY2025 results filed.
Get alerts →Sign in to be told when any of these change.
What this page does not tell you
What could not be judged, and why. Never empty.
- Models not runFair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored.
- FlagsWATCH on 28 of 30 flags judged; 2 red; 2 could not be judged.
- History breakFY2026 step year (revenue -49%) in the 3- and 5-year growth figures: those figures span the accounts before and after it.
- Data gapsPEG (vendor), PEG on our 3-year EPS growth, Business quality: not available yet.
Not applicable to this company · 1
- Altman ZAltman Z is a manufacturing model; a service business has no inventory or plant turnover for it to read.
What this page rests on
✓10 years of annual statements, through FY2026 (Mar-26)✓10 quarters of results✓104 months of month-end prices, adjusted for bonuses and splits○no valuation of ours yet✓business-model card FY2025 · 41 verified
Questions people ask
What is Aster DM Quality Care's share price today?
Aster DM Quality Care last traded at ₹692.10 on the NSE, as of 13 Oct 2026, 1:00 pm IST, up 1.9% on the day, down 3.0% over a year. Its 52-week range is ₹519 to ₹891. The live price is in the app.
What is Aster DM Quality Care's market cap?
Aster DM Quality Care's market capitalisation is about ₹59,221 crore: what it would cost to buy every share at today's price. That makes it the 76th largest mid cap company we cover.
Is Aster DM Quality Care Ltd a large cap, mid cap or small cap?
Aster DM Quality Care Ltd (ASTERDM) is a mid cap company in AMFI's classification for Jan-Jun 2026. SEBI's buckets go by rank on six-month average market capitalisation: the top 100 are large caps, 101 to 250 mid caps, the rest small caps.
What is Aster DM Quality Care Ltd's P/E ratio?
113.24, vs peers 56.6 · 12th of 14. Price divided by last year's earnings per share: how many years of today's profit you pay for.
Is Aster DM Quality Care Ltd overvalued?
Dear, with low confidence: no valuation within 120 days; P/E 113 vs peers 56.6 (12th of 14); P/B 8.8 vs peers 6.8 (8th of 13).
How does Aster DM Quality Care Ltd make money?
Aster DM Healthcare sells hospital services, clinic care, laboratory tests and pharmacy products to patients across five Indian states. It earns mainly by billing patients (cash or credit, including insurance-covered patients), with revenue recognised net of discounts and insurance disallowances.
Who are Aster DM Quality Care Ltd's peers?
Compared with 13 Hospital: Apollo Hospitals Enterprise Ltd, Manipal Health Enterprises Ltd, Max Healthcare Institute Ltd, Fortis Healthcare Ltd, Global Health Ltd and 8 more. The app shows how they compare on every figure.
Is this investment advice?
No. Valarth is a research and learning tool and is not a SEBI-registered investment adviser or research analyst. The figures come from the company's filings and the exchanges; what to do with them is your call.
How did Aster DM Quality Care do last quarter?
Aster DM Quality Care reported revenue of ₹1,311 Cr, up 12.2% on a year earlier and a net profit of ₹29 Cr, down 92.1% in the Jun 2026 quarter.
Who owns Aster DM Quality Care?
Aster DM Quality Care is held by promoters 53.7%, foreign institutions 10.3%, domestic institutions 16.5%.
Does Aster DM Quality Care pay a dividend?
Yes. Aster DM Quality Care's dividend yield is 0.45% at the latest price; the last payout was ₹3.00 a share, ex-dividend 2 Apr 2026.
What do analysts say about Aster DM Quality Care?
12 analysts cover Aster DM Quality Care, and the consensus is buy. A consensus is a count of opinions, not a forecast; read it beside the numbers.
More mid cap companies
Prestige Estates Projects LtdPRESTIGE · ₹61,573 CrRadico Khaitan LtdRADICO · ₹61,032 CrBank of IndiaBANKINDIA · ₹60,733 CrAPL Apollo Tubes LtdAPLAPOLLO · ₹59,902 CrKalyan Jewellers India LtdKALYANKJIL · ₹58,572 CrJindal Stainless LtdJSL · ₹58,278 CrIndian Overseas BankIOB · ₹58,251 CrSchaeffler India LtdSCHAEFFLER · ₹57,704 Cr